Law360, New York ( December 19, 2014, 10:22 AM EST) -- A little more than one year ago, the U.S. Supreme Court decided Federal Trade Commission v. Actavis Inc.[1] and affirmed that antitrust principles apply to reverse payment settlement agreements — those in which a brand-name drug manufacturer pays a potential generic competitor to settle a patent infringement lawsuit filed under the Hatch-Waxman Act and to stay out of the market for a specified time....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.